Avalo Therapeutics, Inc. has filed an amendment to its FORM S-3 registration statement with the Securities and Exchange Commission (SEC) on July 29, 2024. The registration statement pertains to the potential sale of various securities by selling stockholders, including up to 22,357,897 shares of common stock issuable upon conversion of Series C Non-Voting Convertible Preferred Stock, 22,357.897 shares of Series C Non-Voting Convertible Preferred Stock, up to 11,967,526 shares of common stock issuable upon the exercise of warrants, and 11,967,526 warrants to purchase shares of common stock or Series C Non-Voting Convertible Preferred Stock. The registration statement includes details on the rights and preferences of the securities, indemnification agreements, and anti-takeover provisions. Avalo Therapeutics will not receive any proceeds from the sale...Show More

Avalo Therapeutics, Inc. has filed an amendment to its FORM S-3 registration statement with the Securities and Exchange Commission (SEC) on July 29, 2024. The registration statement pertains to the potential sale of various securities by selling stockholders, including up to 22,357,897 shares of common stock issuable upon conversion of Series C Non-Voting Convertible Preferred Stock, 22,357.897 shares of Series C Non-Voting Convertible Preferred Stock, up to 11,967,526 shares of common stock issuable upon the exercise of warrants, and 11,967,526 warrants to purchase shares of common stock or Series C Non-Voting Convertible Preferred Stock. The registration statement includes details on the rights and preferences of the securities, indemnification agreements, and anti-takeover provisions. Avalo Therapeutics will not receive any proceeds from the sale of securities by the selling stockholders but may receive proceeds from the exercise of warrants, which will be used for general corporate purposes. The company's common stock is listed on The Nasdaq Capital Market under the symbol 'AVTX', while the Series C Non-Voting Convertible Preferred Stock and warrants are not listed on any exchange.